SCHEMBL31245902

SCHEMBL31245902

CCCCCCCCCOC(=O)CCCC=O

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DGKA P23743 2/20 0.63
NAAA Q02083 1/20 0.58
HTR2C P28335 1/20 0.56
MGLL Q99685 1/20 0.54
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
DNM1 Q05193 1/20 0.53
MAPT P10636 2/20 0.53
ALDH1A1 P00352 2/20 0.53
THRB P10828 1/20 0.53
CNR1 P21554 1/20 0.53
TSHR P16473 2/20 0.52
RAD52 P43351 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
FAAH O00519 2/20 0.49
PAM P19021 2/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9197024 1.00 DGKA (0.63) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL16899882 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL22602496 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL22602525 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL25297449 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL25253648 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL23875441 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL25273260 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL23768721 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1
SCHEMBL22078521 0.95 DGKA (0.67) DGKANAAAHTR2CMGLLPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP disclosed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO disclosed